NO139169C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer

Info

Publication number
NO139169C
NO139169C NO1128/72A NO112872A NO139169C NO 139169 C NO139169 C NO 139169C NO 1128/72 A NO1128/72 A NO 1128/72A NO 112872 A NO112872 A NO 112872A NO 139169 C NO139169 C NO 139169C
Authority
NO
Norway
Prior art keywords
aminoal
trans
hydroxy
preparation
therapeutically active
Prior art date
Application number
NO1128/72A
Other languages
English (en)
Other versions
NO139169B (no
Inventor
Eugene Boschetti
Darius Molho
Louis Fontaine
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Publication of NO139169B publication Critical patent/NO139169B/no
Publication of NO139169C publication Critical patent/NO139169C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO1128/72A 1971-04-09 1972-04-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer NO139169C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7112668A FR2132570B1 (no) 1971-04-09 1971-04-09

Publications (2)

Publication Number Publication Date
NO139169B NO139169B (no) 1978-10-09
NO139169C true NO139169C (no) 1979-01-31

Family

ID=9075074

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1128/72A NO139169C (no) 1971-04-09 1972-04-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer

Country Status (26)

Country Link
US (1) US3828095A (no)
JP (1) JPS5544738B1 (no)
AR (1) AR192925A1 (no)
AT (1) AT315151B (no)
AU (1) AU463651B2 (no)
BE (1) BE781805A (no)
BR (1) BR7202015D0 (no)
CA (1) CA999010A (no)
CH (1) CH551942A (no)
CS (1) CS171256B2 (no)
DD (1) DD100459A5 (no)
DE (1) DE2216537C2 (no)
ES (1) ES401500A1 (no)
FR (1) FR2132570B1 (no)
GB (1) GB1358803A (no)
HU (1) HU164931B (no)
IE (1) IE36247B1 (no)
IL (1) IL39147A (no)
IT (1) IT998066B (no)
NL (1) NL176453C (no)
NO (1) NO139169C (no)
OA (1) OA03987A (no)
SE (1) SE385692B (no)
SU (1) SU448639A3 (no)
YU (1) YU35102B (no)
ZA (1) ZA722318B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2623314C2 (de) * 1976-05-25 1984-08-02 Hoechst Ag, 6230 Frankfurt 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2818765A1 (de) * 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
NL7905218A (nl) * 1978-07-05 1980-01-08 Beiersdorf Ag Gesubstitueerde 4-aryl-2.5-dihydro-furan-2-onen en 4-aryl-1.5-dihydro-2h-pyrrol-2-onen en werkwijzen voor de bereiding daarvan.
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
SE8004087L (sv) 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
ZA827646B (en) * 1981-11-12 1983-08-31 American Hospital Supply Corp Esters of aryloxypropanolamine derivatives
US4508725A (en) * 1982-12-22 1985-04-02 American Hospital Supply Corporation Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
US10491066B2 (en) 2015-06-16 2019-11-26 Danfoss Editron Oy Method and arrangement for adjusting the magnetization of a permanent magnet machine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660230A (en) * 1968-11-26 1972-05-02 Gen Electric Nuclear reactor control system
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives

Also Published As

Publication number Publication date
NL176453C (nl) 1985-04-16
SU448639A3 (ru) 1974-10-30
CS171256B2 (no) 1976-10-29
YU77172A (en) 1980-03-15
YU35102B (en) 1980-09-25
SE385692B (sv) 1976-07-19
AR192925A1 (es) 1973-03-21
HU164931B (no) 1974-05-28
IT998066B (it) 1976-01-20
IE36247L (en) 1972-10-09
NL7204726A (no) 1972-10-11
FR2132570B1 (no) 1974-08-02
FR2132570A1 (no) 1972-11-24
AU4081872A (en) 1973-10-11
IL39147A (en) 1976-12-31
NL176453B (nl) 1984-11-16
BE781805A (fr) 1972-10-09
DE2216537C2 (de) 1984-08-02
CH551942A (fr) 1974-07-31
ES401500A1 (es) 1975-09-16
IL39147A0 (en) 1972-06-28
NO139169B (no) 1978-10-09
AU463651B2 (en) 1975-07-16
IE36247B1 (en) 1976-09-15
DD100459A5 (no) 1973-09-20
CA999010A (en) 1976-10-26
US3828095A (en) 1974-08-06
OA03987A (fr) 1979-09-15
JPS5544738B1 (no) 1980-11-13
GB1358803A (en) 1974-07-03
ZA722318B (en) 1972-12-27
DE2216537A1 (de) 1972-10-19
AT315151B (de) 1974-05-10
BR7202015D0 (pt) 1975-02-12

Similar Documents

Publication Publication Date Title
NO142441C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO140059C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO137321C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO139169C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoalkoholderivater av trans-hydroksy-kanelsyrer
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO144153C (no) Fremgangsmaate for fremstilling av delta3-7-acylamido-3-metyl-cefem-4-karboksylsyrer
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140821C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140824C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO138561C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme cykloalkylfenoksykarboksylsyrederivater
NO137999C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oxofurylestere av 6-(alfa-aminofenylacetamido)-penicillansyre
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO138285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO140007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolcarboxylsyrer
NO138947C (no) Fremgangsmaate ved fremstilling av 2-alkoxy-5-alkylsulfonyl-benzoesyrer
NO138767C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive nitrosoureaderivater
NO140825C (no) Analogifremgangmaate ved fremstilling av terapeutisk aktive pregnan-21-syrederivater